Transcript Pharmacy reaccredited by URAC

JACKSON, Miss. — Transcript Pharmacy has been reaccredited for an additional three-year period by URAC, an independent, nonprofit healthcare accrediting organization that establishes quality standards for the health care industry. This second term of accreditation falls under URAC’s Specialty Pharmacy 3.0 standards.

 “This recognition demonstrates that the level of care and quality of services we offer bring significant benefits to the patients that we serve,” said Transcript Pharmacy president Cliff Osbon.

Transcript Pharmacy was recognized by Inc. Magazine as one of country’s 5,000 fastest growing private companies.

“It’s necessary for specialty pharmacies to provide a higher level of treatment for patients so desired outcomes are achieved. Transcript Pharmacy shows a dedication to patient education and safety through the recognition of quality it received with URAC’s independent accreditation,” said URAC President and CEO Kylanne Green. “With URAC accreditation, people know that Transcript Pharmacy strives to adhere to industry best practices.”

Transcript Pharmacy is a specialty pharmacy providing services for patients with long-term medical needs. These include patients with solid organ or bone marrow transplants; hepatitis C; rheumatoid arthritis; Crohn’s disease and ulcerative colitis; psoriasis and psoriatic arthritis; multiple sclerosis; patients being treated with oral oncolytics for various cancers; and other conditions.

 “Our staff truly cares about the end result for the patient and we strive for better outcomes," said Osbon. He also noted that Transcript Pharmacy is dually-accredited and holds Board of Pharmacy permits allowing them to serve patients in all 50 states. “We’ve been able to maintain the attributes of a small business while continuing to grow and offer our patients the best care,” Osbon added.